We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $100B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+36.93%
3 Year Est. Return
+93.95%
5 Year Est. Return
+113.13%
10 Year Est. Return
+336.84%
AUM
$67.3B
AUM Growth
-$2.09B
Cap. Flow
-$1.26B
Cap. Flow %
-1.88%
Top 10 Hldgs %
22.59%
Holding
1,667
New
146
Increased
574
Reduced
656
Closed
131

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$241M
2
AON icon
Aon
AON
+$160M
3
BMO icon
Bank of Montreal
BMO
+$157M
4
TU icon
Telus
TU
+$129M
5
CPRT icon
Copart
CPRT
+$126M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Financials 20.78%
3 Industrials 12.2%
4 Healthcare 9.16%
5 Energy 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBS icon
201
UBS Group
UBS
$162B
$54.4M 0.08%
1,848,918
-433,275
-19% -$12.9M
BP icon
202
BP
BP
$118B
$54.3M 0.08%
1,504,737
+104,850
+7% +$3.93M
AMGN icon
203
Amgen
AMGN
$206B
$53.9M 0.08%
172,434
-27,798
-14% -$8.17M
QQQ icon
204
Invesco QQQ Trust
QQQ
$477B
$53.5M 0.08%
111,673
-11,321
-9% -$5.09M
JKS
205
JinkoSolar
JKS
$600M
$53.3M 0.08%
2,572,177
+44,661
+2% +$1.1M
DV icon
206
DoubleVerify
DV
$2.1B
$53M 0.08%
+2,722,926
New +$65.8M
TSLA icon
207
Tesla
TSLA
$1.42T
$52.8M 0.08%
267,048
-15,367
-5% -$2.69M
RSG icon
208
Republic Services
RSG
$68.2B
$52.2M 0.08%
268,611
-2,403
-0.9% -$453K
FISV
209
Fiserv Inc
FISV
$27.1B
$52M 0.08%
349,150
-20,382
-6% -$3.09M
MDT icon
210
Medtronic
MDT
$120B
$51.5M 0.08%
654,839
+148,586
+29% +$12.2M
BSX icon
211
Boston Scientific
BSX
$65.3B
$51.4M 0.08%
667,195
-22,207
-3% -$1.63M
T icon
212
AT&T
T
$182B
$50.5M 0.08%
2,641,856
+288,093
+12% +$5.01M
CVS icon
213
CVS Health
CVS
$122B
$50M 0.07%
846,014
-17,411
-2% -$1.09M
INTC icon
214
Intel
INTC
$514B
$49.1M 0.07%
1,585,764
+208,771
+15% +$6.84M
RBA icon
215
RB Global
RBA
$15.6B
$48.9M 0.07%
641,082
-130,874
-17% -$9.81M
TIXT
216
DELISTED
TELUS International
TIXT
$48.7M 0.07%
8,440,050
+472,103
+6% +$3.3M
EWJ icon
217
iShares MSCI Japan ETF
EWJ
$23.5B
$48.7M 0.07%
713,337
-129,100
-15% -$8.81M
GM icon
218
General Motors
GM
$76.5B
$48.3M 0.07%
1,040,461
-422,650
-29% -$19.1M
BFAM icon
219
Bright Horizons
BFAM
$3.25B
$47.9M 0.07%
435,580
-106,870
-20% -$11.5M
TRV icon
220
Travelers Companies
TRV
$78.9B
$47.5M 0.07%
233,725
-6,611
-3% -$1.42M
TGT icon
221
Target
TGT
$72.1B
$47.3M 0.07%
319,222
+21,639
+7% +$3.4M
EQX icon
222
Equinox Gold
EQX
$13.8B
$46.7M 0.07%
8,953,104
+3,162,992
+55% +$17.6M
CARR icon
223
Carrier Global
CARR
$47.4B
$45.8M 0.07%
726,086
+50,336
+7% +$3.09M
EFX icon
224
Equifax
EFX
$19.9B
$45.5M 0.07%
187,784
-317,815
-63% -$75.8M
MOS icon
225
The Mosaic Company
MOS
$8.01B
$45M 0.07%
1,557,174
-184,508
-11% -$5.56M

Similar funds

Mackenzie Financial's Q2 2024 Portfolio in Review

As of Q2 2024, Mackenzie Financial held 1,667 positions worth $67.3B, down 3% from $69.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Mackenzie Financial's Q2 2024 filing shows 146 new, 574 increased, 656 reduced and 131 closed positions. Its largest new stake was DoubleVerify: 2,722,926 shares worth $53M. The largest sale was SPDR Gold Trust, an estimated $241M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Mackenzie Financial's largest Q2 2024 buy was DoubleVerify: 2,722,926 shares worth $53M.
  • Mackenzie Financial added most to ExxonMobil in Q2 2024, an estimated $187M increase.
  • Mackenzie Financial's biggest Q2 2024 reduction was SPDR Gold Trust, cutting an estimated $241M.
  • Mackenzie Financial fully exited iShares US Medical Devices ETF in Q2 2024, selling an estimated $15.7M.
  • Mackenzie Financial's ten largest holdings make up 23% of its $67.3B portfolio in Q2 2024.
  • Mackenzie Financial opened 146 new positions and closed 131 in Q2 2024.
  • Mackenzie Financial's portfolio value fell 3% quarter-over-quarter to $67.3B.

Based on Mackenzie Financial's 13F filing for Q2 2024, filed 14 Aug 2024.